Sergio Quezada
Founder en ACHILLES THERAPEUTICS PLC .
Fortuna: 466 571 $ al 31/03/2024
Perfil
Sergio Quezada is the founder of Achilles Therapeutics UK Ltd.
(founded in 2016) and Achilles Therapeutics Plc (founded in 2020), where he holds the title of Chief Scientific Officer.
He is currently a Professor-Cancer Institute at University College London since 2011.
Dr. Quezada obtained his undergraduate degree from Pontificia Universidad Católica de Chile and his doctorate from Dartmouth Medical School.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/02/2023 | 373 257 ( 0.92% ) | 466 571 $ | 31/03/2024 |
Cargos activos de Sergio Quezada
| Empresas | Cargo | Inicio |
|---|---|---|
| ACHILLES THERAPEUTICS PLC | Founder | 01/11/2020 |
| University College London | Corporate Officer/Principal | 01/01/2011 |
Antiguos cargos conocidos de Sergio Quezada.
| Empresas | Cargo | Fin |
|---|---|---|
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Founder | - |
Formación de Sergio Quezada.
| Pontificia Universidad Católica de Chile | Undergraduate Degree |
| Dartmouth Medical School | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ACHILLES THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Sergio Quezada
